tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL

Compare Ocular Therapeutix (OCUL) vs. Competitors

1,586 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ocular Therapeutix
$8.34
$1.82B
-8.55
32.38%
10 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$24.49
$2.49B
-34.27
60.07%
11 Buy
1 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$68.76
$2.93B
-51.51
44.79%
8 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$8.30
$833.10M
-36.48%
3 Buy
0 Hold
0 Sell
Strong Buy
Belite Bio, Inc. ADR
$169.79
$6.68B
-69.12
204.99%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCUL
Ocular Therapeutix
8.34
1.50
21.93%
ETNB
BEAM
Beam Therapeutics
24.49
8.12
49.60%
TARS
Tarsus Pharmaceuticals
68.76
22.89
49.90%
SPRY
ARS Pharmaceuticals
8.15
-5.19
-38.91%
BLTE
Belite Bio, Inc. ADR
169.79
114.69
208.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts